The Convenient Choice
As the first conditionally approved drug for canine epilepsy, KBroVet-CA1 pioneers a new era in veterinary medicine. Its once-a-day treatment regimen aligns seamlessly with the busy schedules of modern pet owners, eliminating the hassle of multiple doses. What sets KBroVet-CA1 apart even further is its extended half-life, offering prolonged effectiveness and providing peace of mind to pet owners, knowing their beloved companions are covered even if a dose is missed.
Learn more about canine epilepsy
-
Podcast
Unveiling the mysteries of canine epilepsy
We'll be exploring the latest in epilepsy research and insights with the help of esteemed veterinary neurologists, Dr. Gaemia Tracy and Dr. Fiona James, along with researcher Emily Folkard.
-
CE Program
Decoding Canine Epilepsy
Embark on a transformative exploration with "Decoding Canine Epilepsy," a RACE approved course led by Dr. Gaemia Tracy, a veterinary neurologist with Eastern Pennsylvania Veterinary Specialists.
-
Digital Textbook
Essentials of Epilepsy Management
Authored by veterinary neurologists Dr. Gaemia Tracy, Dr. Rebecca Windsor, and Dr. Ryan Gibson, this guide provides a comprehensive overview for veterinarians navigating the complexities of canine epilepsy.
KBroVet-CA1 is a safe, reliable treatment for idiopathic epilepsy in dogs.
As the first conditionally approved drug for canine epilepsy, KBroVet-CA1 pioneers a new era in veterinary medicine. Its once-a-day treatment regimen aligns seamlessly with the busy schedules of modern pet owners, eliminating the hassle of multiple doses. What sets KBroVet-CA1 apart even further is its extended half-life, offering prolonged effectiveness and providing peace of mind to pet owners, knowing their beloved companions are covered even if a dose is missed. Learn more
Disclaimer
This page includes content sponsored by PRN Pharmacal, makers of KBroVet-CA1.